Cargando…
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design
Pharmaceuticals represent the third-largest expenditure item in health care spending in the OECD countries, and cost growth is around 5% per year in many OECD countries. One possible way to contain the rise in pharmaceutical spending is the use of cost-sharing schemes that makes insured individuals...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666319/ https://www.ncbi.nlm.nih.gov/pubmed/35212886 http://dx.doi.org/10.1007/s10198-022-01446-w |